Abundance Potential

Assessment scope

Development

The reported mouse study linking surface-ectoderm CFL1 to cell behaviors during spinal neural-tube zippering.

Baseline

Mouse developmental-biology knowledge of spinal closure before this study, as described in the article.

Population

Developmental-biology researchers; people affected by neural-tube defects are a conditional future population, not directly studied.

Geography

Global research context; no geography-specific societal outcome is reported.

Target assumptions

Any future human benefit would require the mechanism to be relevant in humans and to support an effective, safe application; neither is established here.

Five dimensions

Human wellbeing

Unknown · The reported result is in mice and does not establish human relevance, prevention, diagnosis, treatment, or a human health outcome. Sources: evidence-1787

Affordability and access

Unknown · The article provides no evidence about costs, access, or delivery of a resulting capability.

Reach and fairness

Unknown · No evidence describes who might receive a future benefit or how it would be distributed.

Environment and resources

Unknown · The supplied evidence does not assess environmental effects or resource use.

Scientific capability

2/4 · The study provides a meaningful but bounded in-vivo mouse result connecting CFL1 with filopodial movement, cell-border constriction, and zippering speed. The proposed sequence remains a model, and the result does not establish the same mechanism in humans. Sources: evidence-1787, evidence-1788, evidence-1789, evidence-1790, evidence-1791

Evidence, confidence and timing

Evidence maturity

Finding: Laboratory. The finding comes from conditional gene deletion and live imaging in mouse embryos; the article excerpt identifies the paper as an uncorrected proof, and the proposed sequence was not observed all at once.

Societal benefit: Early speculative. The study may guide further research, but it does not establish a human application or a direct societal benefit.

Confidence: Low. Confidence is limited to the reported mouse findings: the article is an uncorrected proof, the proposed chain is not fully observed, and human relevance is explicitly unestablished. This is a confidence judgment, not a probability of success.

Conditional time horizon: Unknown. The article describes no application or development schedule, and the steps needed to establish human relevance and practical benefit are not specified.

Possible benefits

• Could provide developmental-biology researchers with a more specific account of cell behaviors associated with mouse spinal closure and guide further mechanistic study; no human health benefit is established. Sources: evidence-1787, evidence-1788, evidence-1789, evidence-1790

Risks and possible harms

• Treating the mouse result as a human risk estimate could mislead health understanding; the article states that it does not establish the same mechanism or risk in humans. Affected groups: People affected by neural-tube defects, prospective parents, and health professionals relying on risk information. Sources: evidence-1787

Distribution and adoption

Who might be excluded

• People and families affected by human neural-tube defects are outside the direct evidence: the reported intervention and outcomes are in mouse embryos. Sources: evidence-1787

Adoption barriers

• The evidence does not establish human relevance or an actionable intervention, and the proposed sequence of cell behaviors remains incompletely observed. Sources: evidence-1787, evidence-1790

Assumptions and conditions that could change the assessment

• Any future human benefit would depend on confirming that the mouse mechanism is relevant to humans; the article does not establish this. Sources: evidence-1787
• Any future application would need to turn the proposed cellular mechanism into a safe and effective capability; no such application is reported. Sources: evidence-1790
• Evidence that the mechanism is relevant in humans and can support a safe, effective application would be needed to assess human wellbeing or access benefits. Sources: evidence-1787
• Further evidence resolving the proposed sequence of cell behaviors could strengthen confidence in the mechanistic account. Sources: evidence-1790

Citations

1. evidence-1787 · CFL1-dependency of discrete cell behaviours driving mouse spinal zippering · A; b; i; g; a; i; l; ; R; .; ; M; a; r; s; h; a; l; l · 10.1371/journal.pbio.3004092 · Captured publisher article text · Open source
2. evidence-1788 · CFL1-dependency of discrete cell behaviours driving mouse spinal zippering · A; b; i; g; a; i; l; ; R; .; ; M; a; r; s; h; a; l; l · 10.1371/journal.pbio.3004092 · Captured publisher article text · Open source
3. evidence-1789 · CFL1-dependency of discrete cell behaviours driving mouse spinal zippering · A; b; i; g; a; i; l; ; R; .; ; M; a; r; s; h; a; l; l · 10.1371/journal.pbio.3004092 · Captured publisher article text · Open source
4. evidence-1790 · CFL1-dependency of discrete cell behaviours driving mouse spinal zippering · A; b; i; g; a; i; l; ; R; .; ; M; a; r; s; h; a; l; l · 10.1371/journal.pbio.3004092 · Captured publisher article text · Open source
5. evidence-1791 · CFL1-dependency of discrete cell behaviours driving mouse spinal zippering · A; b; i; g; a; i; l; ; R; .; ; M; a; r; s; h; a; l; l · 10.1371/journal.pbio.3004092 · Captured publisher article text · Open source